By Shelly Kumar
3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF)(the “Company” or “3DS”) is pleased to announce that it has received the first batch of blood samples for the PRECISE prostate cancer clinical trial (“PRECISE”). The samples were received for processing and analysis at the Company’s new laboratory and corporate headquarters in the MaRS Discovery District,
Bolivia is home to huge lithium resources, but this expert says the country has been too slow to exercise its potential.
Centenera Mining Corporation (TSXV:CT; OTC:CTMIF), reports that detailed surface sampling has commenced at the Company’s El Quemado lithium pegmatite project (“El Quemado” or the “Project”) in Salta Province, northwest Argentina. An exploration team consisting of geologists and support staff recently mobilized to the Project area. The Company plans to complete
Beleave Inc. (“Beleave”) (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it will begin a clinical research program with Dr. Mohit Bhandari, to investigate the therapeutic use of cannabinoids for management of pain in musculoskeletal disorders. In North America, Europe, and Australia, chronic non-cancer pain is a
Gensource Potash (TSXV:GSP) is pleased to announce that both the Company and its Joint Venture Partner, Essel Group ME (“EGME”), have appointed individuals to directorship positions in Vanguard Potash Corporation.
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today provided a shareholder update and highlighted the company’s recent achievements it has reached during the first part of
DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).
Leading Edge Materials Corp. (“Leading Edge Materials”) or (“the Company”) (TSX VENTURE:LEM)(OTCQB:LEMIF) is pleased to announce high grade lithium results from the first five diamond drill holes at the Company’s 100% owned Bergby lithium project in Sweden. Bergby was a new discovery by Leading Edge Materials in 2016, and this
Q BioMed Inc. (OTCQB: QBIO) and ASDERA LLC today announce a licensing agreement that provides Q BioMed with the worldwide exclusive rights to ASDERA’s ASD-002, which is being developed to treat a rare pediatric nonverbal disorder.
Last week’s other top-gaining mining stocks on the TSX were Nautilus Minerals, Arizona Mining, Largo Resources and Coro Mining.
By Melissa Shaw
Last week’s other top-gaining TSXV stocks were Trigon Metals, Sama Resources, First Point Minerals and Newrange Gold.
By Jocelyn Aspa
The Ultimate Software Group, LogMein, HealthStream, RealPage, and Pegasystems were last week’s top stocks on the on the NASDAQ 100 Technology Sector.
CytRx Corporation leads the list of last week’s life science gainers on the NASDAQ, followed by Rockwell Medical, ImmunoGen, NewLink Genetics and TearLab.
By Jocelyn Aspa
Upcoming elections in France and the UK heavily impacted prices on the precious metals sector this week.
Magnis Resources (ASX:MNS) is pleased to announce that it is part of a global consortium led by Boston Energy and Innovation (BEI) which has signed an exclusive MoU with Townsville City Council to investigate building a 15GWh Lithium-ion Battery Manufacturing Plant in Townsville.
Avrupa Minerals Ltd. (TSXV:AVU) is pleased to announce that it has closed the financing to raise $225,000 by way of a private placement of 2.5 million common shares at $0.09 per common share.
Avrupa now has 76,748,797 common shares issued and outstanding. No commissions or finder’s fees were paid for this financing.